Virios shareholders reject proposed reverse stock split at annual meeting

Approval of an amendment to our Certificate of Incorporation to effect a reverse stock split of the outstanding shares of common stock at a ratio of not less than 1-for-2 and not more than 1-for-25, with the exact ratio within this range and the effective time of the reverse stock split determined by our Board of Directors in its sole discretion. The amendment to our Certificate of Incorporation to effect a reverse stock split of the outstanding shares of common stock was not approved by a majority of the shares of common stock outstanding with the following votes tabulated: ​ For Against Abstain Broker Non-Vote 9,011,430 720,787 123,006 —

Ratification of the appointment of FORVIS, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 . The appointment of FORVIS, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified, with the following votes tabulated: ​ For Against Abstain Broker Non-Vote 9,571,787 62,656 220,780 —

Election of Directors . The following seven nominees were elected to serve as directors of the Company, with the following votes tabulated: ​ For Withheld Broker Non-Vote Richard Burch 5,389,868 75,963 4,389,392 Abel De La Rosa, Ph.D. 5,397,974 67,857 4,389,392 Greg Duncan 5,400,496 65,335 4,389,392 David Keefer 5,365,971 99,860 4,389,392 William L. Pridgen, M.D. 5,392,906 72,925 4,389,392 John C. Thomas, Jr. ​ ​ 5,397,965 ​ ​ ​ 67,866 ​ ​ ​ 4,389,392 ​ Richard J. Whitley, M.D. ​ ​ 4,050,497 ​ ​ ​ 1,415,334 ​ ​ ​ 4,389,392 ​ ​